Esperite N.V. | Balance Sheet

Fiscal year is January-December. All values EUR Thousands.
2012
2013
2014
2015
2016
2017
Cash & Short Term Investments
7,088.00
8,557.00
2,097.00
1,449.00
910.00
694
Total Accounts Receivable
9,350.00
8,934.00
11,510.00
11,335.00
8,070.00
5,940
Inventories
1,475.00
519.00
441.00
410.00
350.00
256
Other Current Assets
3,531.00
674.00
240.00
392.00
212.00
1,310
Total Current Assets
21,444.00
18,684.00
14,288.00
13,586.00
9,542.00
8,200
Net Property, Plant & Equipment
10,167.00
8,644.00
10,382.00
10,552.00
9,554.00
6,742
Total Investments and Advances
-
29.00
58.00
79.00
-
641
Long-Term Note Receivable
1,224.00
751.00
1,290.00
1,502.00
1,417.00
1,486
Intangible Assets
22,169.00
22,754.00
20,190.00
21,015.00
19,703.00
14,871
Total Assets
55,621.00
51,252.00
46,786.00
48,136.00
42,480.00
33,883
ST Debt & Current Portion LT Debt
201.00
202.00
213.00
424.00
235.00
Accounts Payable
2,398.00
2,385.00
4,086.00
8,146.00
8,642.00
Income Tax Payable
592.00
43.00
280.00
301.00
73.00
Other Current Liabilities
6,119.00
6,573.00
4,380.00
5,133.00
7,490.00
Total Current Liabilities
9,310.00
9,203.00
8,959.00
14,004.00
16,440.00
Long-Term Debt
3,212.00
3,003.00
4,008.00
5,449.00
5,339.00
Provision for Risks & Charges
-
-
321.00
843.00
1,265.00
Deferred Taxes
1,244.00
1,192.00
425.00
367.00
1,364.00
Other Liabilities
11,408.00
10,695.00
11,204.00
11,552.00
11,865.00
Total Liabilities
25,791.00
24,483.00
25,495.00
32,883.00
35,809.00
Common Equity (Total)
29,830.00
26,769.00
21,278.00
15,390.00
6,939.00
Total Shareholders' Equity
29,830.00
26,769.00
21,278.00
15,390.00
6,939.00
Total Equity
29,830.00
26,769.00
21,291.00
15,253.00
6,671.00
Liabilities & Shareholders' Equity
55,621.00
51,252.00
46,786.00
48,136.00
42,480.00
Accumulated Minority Interest
-
-
13.00
137.00
268.00

About Esperite

View Profile
Address
Herengracht 282
Amsterdam Noord-Holland 1016 BX
Netherlands
Employees -
Website http://www.esperite.com
Updated 07/08/2019
Esperite NV engages in regenerative and predictive medicine. It operates through the following business segments: The extraction and storage of adult human stem cells, Research and Development, Predictive medicine, and Other types of products and services. The extraction and storage of adult human stem cells segment refers to the tem cells collected from the umbilical cord blood, and the umbilical cord itself, at birth and from adipose tissue.